Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học Wertheim cung cấp cho các bạn kiến thức về ngành y đề tài: Changes in Two Point Discrimination and the law of mobility in Diabetes Mellitus patients. | Journal of Brachial Plexus and Peripheral Nerve Injury BioMed Central Research article Changes in Two Point Discrimination and the law of mobility in Diabetes Mellitus patients R Periyasamyt1 M Manivannan 1 and Vengesana Balakrish Raja Narayanamurthy 2 Open Access Address Biomedical Engineering Group Department of Applied Mechanics Indian Institute of Technology Madras Chennai 600036 India and 2Diabetic Foot Clinic Sundaram Medical Foundation Chennai 600040 India Email R Periyasamy - periyasamy25@ M Manivannan - mani@ Vengesana Balakrish Raja Narayanamurthy - vbnmurthy@ Corresponding author fEqual contributors Published 29 January 2008 Received 2 November 2007 Journal of Brachial Plexus and Peripheral Nerve Injury 2008 3 3 doi 1749-7221-3-3 Accepted 29 January 2008 This article is available from http content 3 1 3 2008 Periyasamy et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http licenses by which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract Background Diabetic neuropathy is a family of nerve disorders with progressive loss of nerve function in 15 of diabetes mellitus DM subjects. Two-point discrimination TPD is one method of quantitatively testing for loss of nerve function. The law of mobility for TPD is known for normal subjects in earlier studies but has not been studied for diabetic subjects. This is a pilot study to evaluate and plot the law of mobility for TPD among DM subjects. Methods The Semmes Weinstein monofilament SWMF was used to measure the loss of protective sensation. An Aesthesiometer was used to find the TPD of several areas in upper and lower extremities for normal and diabetic subjects. All the subjects were screened for peripheral artery occlusive disease with ankle brachial pressure index or above
